BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3029269)

  • 1. Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.
    Faas SJ; Pan S; Pinkert CA; Brinster RL; Knowles BB
    J Exp Med; 1987 Feb; 165(2):417-27. PubMed ID: 3029269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune control of SV40-induced tumors in mice.
    Pan S; Abramczuk J; Knowles BB
    Int J Cancer; 1987 Jun; 39(6):722-8. PubMed ID: 3034805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
    Ye X; McCarrick J; Jewett L; Knowles BB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic selection of simian virus 40 (SV40) T-antigen-negative tumor cells which arise by excision of early SV40 DNA.
    Mora PT; Parrott CL; Baksi K; McFarland V
    J Virol; 1986 Sep; 59(3):628-34. PubMed ID: 3016325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of SV40-specific cytotoxic T-lymphocyte precursors in two SV40 T-antigen transgenic mouse lines.
    Juretic A; Knowles BB
    APMIS; 1991 Mar; 99(3):213-8. PubMed ID: 1850285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas.
    Schell TD; Knowles BB; Tevethia SS
    Cancer Res; 2000 Jun; 60(11):3002-12. PubMed ID: 10850449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
    Shearer MH; Bright RK; Lanford RE; Kennedy RC
    Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid vaccination against virally induced tumors.
    Bright RK; Shearer MH; Kennedy RC
    Ann N Y Acad Sci; 1995 Nov; 772():241-51. PubMed ID: 8546399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
    Fresa KL; Karjalainen HE; Tevethia SS
    J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.
    Schell TD
    J Virol; 2004 Feb; 78(4):1751-62. PubMed ID: 14747540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SV40 T antigen acts as a minor histocompatibility antigen of SV40 T antigen tolerant transgenic mice.
    Juretic A; Knowles BB
    Immunogenetics; 1989; 29(6):366-70. PubMed ID: 2786497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a simian virus 40 T-antigen-positive, transformation-resistant cell line by indirect selection.
    Ryan KW; Christensen JB; Imperiale MJ; Brockman WW
    Mol Cell Biol; 1985 Dec; 5(12):3577-82. PubMed ID: 3018524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.
    Schell TD; Mylin LM; Georgoff I; Teresky AK; Levine AJ; Tevethia SS
    J Virol; 1999 Jul; 73(7):5981-93. PubMed ID: 10364350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts.
    Jat PS; Sharp PA
    J Virol; 1986 Sep; 59(3):746-50. PubMed ID: 3016337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluctuation of simian virus 40 (SV40) super T-antigen expression in tumors induced by SV40-transformed mouse mammary epithelial cells.
    Butel JS; Wong C; Evans BK
    J Virol; 1986 Nov; 60(2):817-21. PubMed ID: 3022016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenesis in transgenic mice by a nuclear transport-defective SV40 large T-antigen gene.
    Pinkert CA; Brinster RL; Palmiter RD; Wong C; Butel JS
    Virology; 1987 Sep; 160(1):169-75. PubMed ID: 2820126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SV40 T-antigen is a histocompatibility antigen of SV40-transgenic mice.
    Wettstein PJ; Jewett L; Faas S; Brinster RL; Knowles BB
    Immunogenetics; 1988; 27(6):436-41. PubMed ID: 2836306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.